• linkedin
  • Increase Font
  • Sharebar

    CVS pharmacy sales offset lost tobacco revenues

    CVS Caremark reported a drop in front-store sales as a result of its decision to phase out tobacco products, but pharmacy sales drove second-quarter earnings past Wall Street expectations.

    CVS reported second-quarter earnings increased 11%. CVS officials attributed the earnings increase to specialty drug sales through its retail outlets and its pharmacy benefits manager (PBM).

    See Drug Topics’ Stories of the Month

    CVS reported that revenue from its PBM increased 16%. Operating profits from the PBM jumped 30%. Pharmacy same-store sales increased 5%, driving overall same-store sales up 3.3%.

    CVS CEO Larry Merlo said the PBM gives the company a chance to "not just manage the specialty drug but manage the specialty patient."

    Mark Lowery, Editor
    Mark Lowery an Editor for Drug Topics magazine.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available